Paracentesis for malignant ascites is usually performed as an in-patient procedure, with a median length of stay (LoS) of 3–5 days, with intermittent clamping of the drain due to a perceived risk of ...

FRANKLIN LAKES, N.J., June 23, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from ...

An apple a day may keep the doctor away, but an at-home catheter system from BD has the potential to keep the entire hospital away. The PeritX system allows patients with ascites to regularly drain ...

Validation of urinary HE4 as a biomarker for ovarian cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component.

Ovarian cancer is one of the deadliest cancers affecting women. One reason it is so dangerous is that it is often discovered ...

ASCITES is a problem frequently encountered and often unsatisfactorily treated. An adjunct in the therapy of ascites has been tried in a limited number of cases and has seemed sufficiently helpful to ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced receipt of the FDA’s 510(k) clearance for its PeritX Peritoneal Catheter System. The system is to be used for the drainage ...

You may send us your comments on this form by clicking the button below. You will first be asked to supply your name, email address, and location. You must then acknowledge our data protection ...

A fluid that women with advanced ovarian cancer know all too well - ascites, the buildup of liquid in the belly - may be ...

Ascites—the buildup of liquid in the belly—may be doing more than causing discomfort. A Duke University School of Medicine ...

We have moved medical technologies guidance 9 to become HealthTech guidance 282. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme ...